Plasma and intracellular pk and renal safety of TAF 25mg with boosted PIs and LDV/SOF [abstract 449]

Brooks KM, Castillo-Mancilla J, Morrow M, et al. Plasma and intracellular pk and renal safety of TAF 25mg with boosted PIs and LDV/SOF [abstract 449]. Presented at Conference on Retroviruses and Opportunistic Infections. March 8-11, 2020. Boston, Massachusetts; 2020.

Publication Type:

Conference Proceedings

Authors:

Brooks, KM; Castillo-Mancilla, J; Morrow, M; et, al

Source:

Presented at Conference on Retroviruses and Opportunistic Infections. March 8-11, 2020, Boston, Massachusetts (2020)

Cited On:

Export Citation:
RIS Format
Top